<DOC>
	<DOCNO>NCT01864915</DOCNO>
	<brief_summary>Colon capsule endoscopy new technology noninvasive method examine large bowel . The bowel preparation require test differs colonoscopy need clean colon also need provide propulsion . Most published study use medication part regime available part North America ( ex . sodium phosphate ) show poor test completion , bowel preparation polyp detection rate . Objective : In study bowel preparation colon capsule propose uses medication approve use Canada may provide good preparation quality good completion rate . Methods : Patients refer colonoscopy recruit participate study . They receive split-dose polyethylene glycol ( PEG ) bowel preparation . They randomize receive either 1 ) Prucalopride 2mg daily four day , 2 ) Prucalopride 2mg daily four day plus Prucalopride booster , 3 ) Prucalopride 2mg four day plus 1 1/2 sachet Picosalax booster colon capsule study . The day colon capsule drink PEG ( 2 Liters ) 5am -or approx 4hrs prior procedure time return colonoscopy . The colon capsule result review two endoscopists experience video capsule endoscopy ass bowel preparation use previously define scale examine polyp . We propose administer Prucalopride daily 4 day increase intestinal motility improve colon capsule completion rate booster dose Picosalax improve colon capsule completion rate compare prucalopride .</brief_summary>
	<brief_title>Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster Colon Capsule</brief_title>
	<detailed_description>Colon capsule endoscopy new technology noninvasive method examine large bowel . The bowel preparation require test differs colonoscopy need clean colon also need provide propulsion . Most published study use medication part regime available part North America ( ex . sodium phosphate ) show poor test completion , bowel preparation polyp detection rate . Objective : In study bowel preparation colon capsule propose uses medication approve use Canada may provide good preparation quality good completion rate . Methods : Patients refer colonoscopy recruit participate study . They receive split-dose polyethylene glycol ( PEG ) bowel preparation . They randomize receive either 1 ) Prucalopride 2mg daily four day , 2 ) Prucalopride 2mg daily four day plus Prucalopride booster , 3 ) Prucalopride 2mg four day plus 1 1/2 sachet Picosalax booster colon capsule study . The day colon capsule drink PEG ( 2 Liters ) 5am -or approx 4hrs prior procedure time return colonoscopy . The colon capsule result review two endoscopists experience video capsule endoscopy ass bowel preparation use previously define scale examine polyp . We propose administer Prucalopride daily 4 day increase intestinal motility improve colon capsule completion rate booster dose Picosalax improve colon capsule completion rate compare prucalopride</detailed_description>
	<criteria>Patients age 1875 refer colonoscopy symptom dysphagia problem swallow , bowel obstruction ileus , know stricture fistula , inflammatory bowel disease , previous small large bowel surgery , severe gastroparesis motility disorder , severe renal impairment ( define lab test result eGFR ie . estimate Glomerular Filtration Rate le 55 within three month study ) , congestive heart failure ( NYHA III IV ) , ischemic heart disease ( acute event last 6mths ) , decompensated cirrhosis severe hepatic dysfunction ( ascites know lab test INR &gt; 2 ) , history serious arrhythmia severe clinically unstable concomitant disease ( eg . lung disease , neurological psychiatric disorder , cancer , AIDS endocrine disorder ) , diabetic treatment insulin hypoglycemic , pregnant nursing woman , galactose intolerance ( since tablet contain lactose monohydrate , patient rare hereditary problem galactose intolerance , Lapp lactase deficiency glucose/galactose malabsorption must take medicinal product . ) know hypersensitivity drug ingredient formulation ( 2mg tablet contains prucalopride 2 mg. Nonmedicinal ingredient : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal silicon dioxide , magnesium stearate ; coating : hypromellose , lactose monohydrate , triacetin , titanium dioxide , macrogol 3000 , iron oxide red , iron oxide yellow , FD &amp; C Blue No . 2 Aluminum Lake ) Females child bear potential unwilling use appropriate birth control method study able participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>colon capsule</keyword>
	<keyword>bowel preparation</keyword>
	<keyword>booster</keyword>
	<keyword>prucalopride</keyword>
	<keyword>picosalax</keyword>
</DOC>